• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Cowen Inc. (Amendment)

    2/9/23 11:15:26 AM ET
    $COWN
    Investment Bankers/Brokers/Service
    Finance
    Get the next $COWN alert in real time by email
    SC 13G/A 1 tv0672-cowenincclassa.htm SCHEDULE 13G/A cowenincclassa

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G

    Under the Securities Exchange Act of 1934
    (Amendment No.: 3)*

    Name of issuer:  Cowen Inc. Class A

    Title of Class of Securities:  Common Stock

    CUSIP Number:  223622606

    Date of Event Which Requires Filing of this Statement: December 30, 2022

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the following page(s))

     

     

    13G

    CUSIP No.:  223622606

    1.  NAME OF REPORTING PERSON
    I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

    The Vanguard Group - 23-1945930

    2.  CHECK THE APPROPRIATE [LINE] IF A MEMBER OF A GROUP

    A. 

    B.  X

    3.  SEC USE ONLY

    4.  CITIZENSHIP OF PLACE OF ORGANIZATION

    Pennsylvania

    (For questions 5-8, report the number of shares beneficially owned by each reporting person with:)

    5.  SOLE VOTING POWER

    0

    6.  SHARED VOTING POWER

    18,952

    7.  SOLE DISPOSITIVE POWER

    1,290,040

    8.  SHARED DISPOSITIVE POWER

    42,301

    9.  AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    1,332,341

    10.  CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    N/A

    11.  PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

    4.76%

    12.  TYPE OF REPORTING PERSON

    IA

     

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Schedule 13G
    Under the Securities Act of 1934

    Item 1(a) - Name of Issuer:

    Cowen Inc. Class A

    Item 1(b) - Address of Issuer's Principal Executive Offices:

    599 Lexington Avenue
    New York, NY 10022

    Item 2(a) - Name of Person Filing:

    The Vanguard Group - 23-1945930

    Item 2(b) – Address of Principal Business Office or, if none, residence:

    100 Vanguard Blvd.
    Malvern, PA 19355

    Item 2(c) – Citizenship:

    Pennsylvania

    Item 2(d) - Title of Class of Securities:

    Common Stock

    Item 2(e) - CUSIP Number

    223622606

    Item 3 - Type of Filing:

    This statement is being filed pursuant to Rule 13d-1.  An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E).

    Item 4 - Ownership:

      (a) Amount Beneficially Owned:

      (b) Percent of Class:

     

     

    (c)  Number of shares as to which such person has:

    (i)  sole power to vote or direct to vote:  

    (ii)  shared power to vote or direct to vote:  

    (iii)  sole power to dispose of or to direct the disposition of:  

    (iv)  shared power to dispose or to direct the disposition of:  

    Comments:

    The responses to questions 5 through 9 and 11 on the cover page(s) are incorporated by reference into this Item 4.  

    Item 5 - Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒

    Item 6 - Ownership of More Than Five Percent on Behalf of Another Person:

    The Vanguard Group, Inc.'s clients, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.

    No one other person's interest in the securities reported herein is more than 5%.

    Item 7 - Identification and Classification of the Subsidiary Which Acquired The Security Being Reported on by the Parent Holding Company:

    Not applicable

    Item 8 - Identification and Classification of Members of Group:

    Not applicable

    Item 9 - Notice of Dissolution of Group:

    Not applicable

    Item 10 - Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

    Signature

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date:  February 9, 2023

    By /s/ Ashley Grim
    Name: Ashley Grim
    Title:  Head of Global Fund Administration

    Get the next $COWN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $COWN

    DatePrice TargetRatingAnalyst
    9/21/2021$35.00Sell
    Goldman Sachs
    More analyst ratings

    $COWN
    SEC Filings

    See more
    • SEC Form 15-12G filed by Cowen Inc.

      15-12G - COWEN INC. (0001466538) (Filer)

      3/13/23 8:34:11 AM ET
      $COWN
      Investment Bankers/Brokers/Service
      Finance
    • Cowen Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Leadership Update, Other Events, Financial Statements

      8-K - COWEN INC. (0001466538) (Filer)

      3/1/23 4:10:46 PM ET
      $COWN
      Investment Bankers/Brokers/Service
      Finance
    • SEC Form S-8 POS filed by Cowen Inc.

      S-8 POS - COWEN INC. (0001466538) (Filer)

      3/1/23 9:23:55 AM ET
      $COWN
      Investment Bankers/Brokers/Service
      Finance

    $COWN
    Leadership Updates

    Live Leadership Updates

    See more
    • Forge Global Appoints Capital Markets Veteran Larry Leibowitz to its Board of Directors

      Forge Global Holdings, Inc. (NYSE:FRGE) ("Forge"), a global private securities marketplace, announced today the appointment of Larry Leibowitz to its Board of Directors, as well as its Compensation Committee. Mr. Leibowitz brings to Forge decades of entrepreneurial and corporate leadership experience in capital markets, financial technology and asset management. He is currently the CEO of Entrypoint Capital, a quantitative investment management firm, and has also held executive and board positions at a myriad of other companies in the financial services and investment sectors, including as the Chief Operating Officer, Head of Global Equities Markets, and Member of the Board of Directors o

      3/14/24 4:10:00 PM ET
      $CNDA
      $CNDB
      $ENFN
      $FRGE
      Blank Checks
      Finance
      Computer Software: Prepackaged Software
      Technology
    • Cowen Strengthens Equity Capital Markets Team With the Appointment of Brian Hagerty as Managing Director, Biotechnology

      NEW YORK , Feb. 28, 2022 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) ("Cowen" or the "Company") today announced that Brian Hagerty has joined the company's Equity Capital Markets team as a Managing Director focused on biotechnology. Mr. Hagerty will be based in New York and report to Grant Miller, Managing Director and Head of Capital Markets, and will work closely with Cowen's Senior Healthcare Capital Markets team of Managing Directors, Mariel Healy, and Michael Campbell. "We are thrilled to welcome Brian to Cowen's long-tenured Healthcare Capital Markets team, especially at this time when experience is paramount as we advise our clients through the current landscape," said Mr. Miller.

      2/28/22 7:45:00 AM ET
      $COWN
      Investment Bankers/Brokers/Service
      Finance
    • Cowen Appoints Lorence Kim as New Independent Board Director

      NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Cowen Inc. (NASDAQ:COWN) ("Cowen" or the "Company") is pleased to announce that Lorence Kim, M.D., has been appointed to its Board of Directors, effective February 15, 2022. The appointment will increase the size of Cowen's Board to nine members. "With his background in both health care and finance, Lorence is a tremendous addition to our Board," said Jeffrey M. Solomon, Chair and Chief Executive Officer of Cowen. "As a well-respected member of the biotech community, Lorence brings his valuable operating experience and detailed understanding of a very important industry for us at Cowen. We look forward to his perspectives and expertise as we con

      2/15/22 4:00:00 PM ET
      $COWN
      Investment Bankers/Brokers/Service
      Finance